TCF-1 and TOX regulate the memory formation of intestinal group 2 innate lymphoid cells in asthma.

Bao, Kaifan; Gu, Xiaoqun; Song, Yajun; Zhou, Yijing; Chen, Yanyan; Yu, Xi; Yuan, Weiyuan; Shi, Liyun et al. · Nat Commun · 2024

basic_science · Level V

Where this comes from

Abstract

Immune memory has been expanded to group 2 innate lymphoid cells (ILC2s), but the cellular and molecular bases remain incompletely understood. Based on house dust mite (HDM)-induced mice asthma models and human samples, we applied flow cytometry, parabiosis, in vivo imaging and adoptive transplantation to confirm the persistence, migration and function of CD45<sup>+</sup>lineage<sup>-</sup>CD90.2<sup>+</sup>NK1.1<sup>-</sup>NKp46<sup>-</sup>ST2<sup>-</sup>KLRG1<sup>+</sup>IL-17RB<sup>+</sup> memory-like ILC2s (ml-ILC2s). Regulated by CCR9/CCL25 and S1P signaling, ml-ILC2s reside in the lamina propria of small intestines (siLP) in asthma remission, and subsequently move to airway upon re-encountering antigens or alarmins. Furthermore, ml-ILC2s possess properties of longevity, potential of rapid proliferation and producing IL-13, and display transcriptional characteristics with up-regulation of Tox and Tcf-7. ml-ILC2s transplantation restore the asthmatic changes abrogated by Tox and Tcf7 knockdown. Our data identify siLP ml-ILC2s as a memory-like subset, which promotes asthma relapse. Targeting TCF-1 and TOX might be promising for preventing asthma recurrence.

Medical subject headings